Search - tctmd.com

Displaying 221 - 240 of 343

Sort: Relevancy | Date

Presentation TCT 2015

Just How Effective Is Hypothermia in Cardiac Arrest?

Presenter: Tanveer Rab, Holger Thiele, Michel R. Le May

October 14, 2015

Presentation TCT 2015

The Role (and Timing) of Complete Revascularization in AMI and Cardiogenic Shock

Presenter: Tanveer Rab, Holger Thiele

October 14, 2015

Presentation TCT 2015

Escalation Therapies and RV Dysfunction: New Opportunities

Presenter: Tanveer Rab, Holger Thiele, Navin K. Kapur

October 14, 2015

Presentation TCT 2015

Debate: What Support Device Should Most Frequently Be Used in Cardiogenic Shock? ECMO for True Shock!

Presenter: Tanveer Rab, Holger Thiele, Aly El Banayosy

October 14, 2015

Presentation TCT 2015

Debate: What Support Device Should Most Frequently Be Used in Cardiogenic Shock? IABP Is Still Frontline!

Presenter: Tanveer Rab, Holger Thiele, Sunil V. Rao

October 14, 2015

Presentation TCT 2015

What Support Device Should Most Frequently Be Used in Cardiogenic Shock? Impella for Most!

Presenter: Tanveer Rab, Holger Thiele, Jose P.S. Henriques

October 14, 2015

Presentation TCT 2015

The Spectrum of Hemodynamic Support Options for Shock

Presenter: Tanveer Rab, Holger Thiele, Vladimir Dzavik

October 14, 2015

Presentation TCT 2015

The Role of the Life Vest, ICDs, and BiV Pacing in Patients With LV Dysfunction

Presenter: Robert O. Bonow, Ajay J. Kirtane, William T. Abraham

October 14, 2015

Presentation TCT 2015

Temporary Cardiac Support During High-Risk PCI: HeartMate PHP and the SHIELD I Study

Presenter: Robert O. Bonow, Ajay J. Kirtane, David E. Kandzari

October 14, 2015

Presentation TCT 2015

The Role of Hemodynamic Support in Nonemergent PCI and LV Dysfunction

Presenter: Robert O. Bonow, Ajay J. Kirtane, Brij Maini

October 14, 2015

Presentation TCT 2015

Case Presentation: How We Treated MVD With LV Dysfunction With Intermediate SYNTAX Score

Presenter: Robert O. Bonow, Ajay J. Kirtane, Adriano Caixeta

October 14, 2015

Presentation TCT 2015

I Would Treat This Patient With PCI

Presenter: Robert O. Bonow, Ajay J. Kirtane

October 14, 2015

Presentation TCT 2015

I Would Treat This Patient With Surgery

Presenter: Robert O. Bonow, Ajay J. Kirtane, Joseph F. Sabik

October 14, 2015

Presentation TCT 2015

I Would Treat This Patient Conservatively (Medications First)

Presenter: Robert O. Bonow, Ajay J. Kirtane, Mark Goldberger

October 14, 2015

Presentation TCT 2015

Evidence Review: Revascularization in LV Dysfunction After STICH Who Might Benefit?

Presenter: Robert O. Bonow, Ajay J. Kirtane

October 14, 2015

Presentation TCT 2015

Case Presentation at Baseline: MVD With LV Dysfunction With Intermediate SYNTAX Score

Presenter: Robert O. Bonow, Ajay J. Kirtane, Adriano Caixeta

October 14, 2015

Presentation TCT 2015

High-Risk Intervention: Risk for the Operators or the Patient? Reconciling Risk Scores, Appropriateness, Public Reporting, and Institutional Needs

Presenter: Philippe Généreux, Brij Maini, Robert W. Yeh

October 14, 2015

Presentation TCT 2015

CHIP: Overview of an Unmet Need

Presenter: Philippe Généreux, Brij Maini, Ajay J. Kirtane

October 14, 2015

Presentation TCT 2015

TCT 75: Cangrelor Improves Ischemic Outcomes in Patients With Multivessel Disease and Single Vessel Disease Undergoing PCI Insights From the CHAMPION PHOENIX Trial

Presenter: Lisa K. Jennings, Neal S. Kleiman, Freddy Abnousi

October 13, 2015

Presentation TCT 2015

TCT 1: High Number of Angiographic Significant Lesions Are FFR Negative in STEMI Patients With Multivessel Disease Preliminary Insight Into the COMPARE-ACUTE Trial

Presenter: Eric Boersma, Richard Smalling, Pieter C. Smits

October 13, 2015

Advertisement

Just How Effective Is Hypothermia in Cardiac Arrest?

The Role (and Timing) of Complete Revascularization in AMI and Cardiogenic Shock

Escalation Therapies and RV Dysfunction: New Opportunities

Debate: What Support Device Should Most Frequently Be Used in Cardiogenic Shock? ECMO for True Shock!

Debate: What Support Device Should Most Frequently Be Used in Cardiogenic Shock? IABP Is Still Frontline!

What Support Device Should Most Frequently Be Used in Cardiogenic Shock? Impella for Most!

The Spectrum of Hemodynamic Support Options for Shock

The Role of the Life Vest, ICDs, and BiV Pacing in Patients With LV Dysfunction

Temporary Cardiac Support During High-Risk PCI: HeartMate PHP and the SHIELD I Study

The Role of Hemodynamic Support in Nonemergent PCI and LV Dysfunction

Case Presentation: How We Treated MVD With LV Dysfunction With Intermediate SYNTAX Score

I Would Treat This Patient With PCI

I Would Treat This Patient With Surgery

I Would Treat This Patient Conservatively (Medications First)

Evidence Review: Revascularization in LV Dysfunction After STICH Who Might Benefit?

Case Presentation at Baseline: MVD With LV Dysfunction With Intermediate SYNTAX Score

High-Risk Intervention: Risk for the Operators or the Patient? Reconciling Risk Scores, Appropriateness, Public Reporting, and Institutional Needs

CHIP: Overview of an Unmet Need

TCT 75: Cangrelor Improves Ischemic Outcomes in Patients With Multivessel Disease and Single Vessel Disease Undergoing PCI Insights From the CHAMPION PHOENIX Trial

TCT 1: High Number of Angiographic Significant Lesions Are FFR Negative in STEMI Patients With Multivessel Disease Preliminary Insight Into the COMPARE-ACUTE Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content